Clinical Trial Update: Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF [Phase 2]

View source ↗

Summary

Tenax Therapeutics conducted a Phase 2 trial to evaluate the hemodynamic effects of levosimendan in patients with pulmonary hypertension associated with heart f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension
• Right-sided Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Tenax Therapeutics, Inc. | Conditions: Hypertension Pulmonary Secondary, Heart Failure, Right Sided | Phase 2 | Status: COMPLETED | Results posted: 2024-05-14